FDA expands use of hair loss prevention system offer by local cancer doctors
The PAXMAN Scalp Cooling System has now been cleared by the US Food and Drug Administration (FDA) to prevent hair loss in patients with solid tumors such as ovarian, breast, colorectal, bowel and prostate cancer. The FDA originally cleared the scalp cooling system only for breast cancer patients receiving Taxane or Anthycycline regimens.
OHC, the region’s leading experts in the treatment of nearly every form of adult cancer and complex blood disorder, is the exclusive regional provider of the Paxman Scalp Cooling System.
The expanded FDA clearance paves the way for more people to use PAXMAN Scalp Cooling, from an estimated 250,000 breast cancer patients to more than one million breast cancer and solid tumor cancer patients. Since its original FDA clearance in April 2017, PAXMAN has installed around 225 scalp cooling systems in the US with a further 65 systems awaiting delivery and installation.
“Not only does the system have the potential to prevent hair loss, it can instill a sense of confidence and strength as well as provide privacy,” said Karyn M. Dyehouse, MD, Chief Medical Officer with OHC. “One of our patients didn’t want her coworkers to know she had cancer, so she used the PAXMAN system and was able to complete her chemotherapy without losing her hair. None of her ever knew coworkers she had cancer.”
Hair loss is a well-known side effect of many chemotherapy regimens, with many men and women reporting it to be the most traumatic aspect of their treatment. Scalp cooling provides a proven alternative to hair loss, resulting in a high level of retention or even complete hair preservation, improving patients’ self-confidence and creating positive attitudes towards treatment.
Scalp cooling works by reducing the temperature of the scalp by a few degrees immediately before, during and after the administration of chemotherapy. This in turn reduces the blood flow to hair follicles, which may prevent or minimize the hair loss. Although successful scalp cooling depends on many factors, research and studies have shown that scalp cooling can be effective across a wide range of chemotherapy regimen.
“We’ve had patients consider skipping chemotherapy due to the possibility of hair loss,” said Dr. Dyehouse. “For some women, it has a strong impact because their hair is part of who they are. One woman said she had always had long brown hair. It’s how her small children know her. She didn’t want them to have memories of her in wigs and hats or nothing. For these women, and men, we can now offer them an option.”
The PAXMAN Scalp Cooling System was developed by the Paxman family to reduce hair loss in cancer patients undergoing chemotherapy. The concept behind the technology came when mother of four, Sue Paxman, experienced first-hand the trauma of chemotherapy induced hair loss. The company has since been on a personal journey to ensure Sue’s legacy lives on by helping people around the globe minimize chemotherapy-induced hair loss and contribute to their quality of life.
Typically, patients select four treatments, which cost $1300. Some insurance carriers may cover the cost. Financial assistance is also available. To learn more, call OHC at 1-888-649-4800 or visit ohcare.com.
At OHC, the search for new treatments is relentless, the drive to provide superior care runs deep and the fight against cancer is personal. Our independent, physician-led practice is recognized for going beyond clinical excellence, providing unrestricted personal support and genuine emotional caring in familiar, neighborhood locations throughout the region. At OHC, renowned experts aggressively attack your cancer with every possible strategy. Our in-house, nationally-recognized clinical trials team is engaged in a passionate search for innovative treatment options, and counselors and advisors help you manage finances, understand your disease and gain power over cancer’s impact on your personal life. At its heart, our approach to cancer care is simple – to surround patients with everything they need to focus on what matters most: beating cancer. For more information, visit ohcare.com.